Lifeline Endocardial Bipolar Lead 484-03
Intermedics
FDA Clearance Information
The Lifeline Endocardial Bipolar Lead 484-03 was cleared through the FDA 510(k) pathway on October 24, 1985. Manufactured by Intermedics, it is classified as a Class III device.
What It Is
FDA-Cleared Indications
- Use as an endocardial bipolar lead with a compatible cardiac pacemaker system.
- Provide cardiac pacing for patients with conditions requiring electrical stimulation of the heart.
Clinical Applications
- Endocardial lead placement during implantation of a permanent pacemaker system.
- Delivery of pacing impulses to the heart in patients who require long-term cardiac pacing.
- Sensing cardiac electrical activity through a bipolar pacing configuration.
- Management of bradyarrhythmias or conduction disorders when pacemaker therapy is indicated.
Practical Considerations
- Verify connector type, electrical specifications, lead dimensions and overall compatibility with the intended pacemaker generator before implantation.
- Lead placement and testing should be performed by qualified cardiac specialists using appropriate fluoroscopic and electrical measurements.
- The record provided does not establish that this specific lead is MRI conditional; MRI safety should be confirmed from the original labeling and the complete implanted system.
- Assess for patient-specific contraindications to transvenous lead implantation, including active infection, significant venous obstruction or anatomy that prevents safe placement.
- Lead longevity varies with implant conditions, mechanical stress, electrical performance and generator replacement history; ongoing pacemaker follow-up is required.
Frequently Asked Questions
What is the Lifeline Endocardial Bipolar Lead 484-03 used for?
It is used for cardiac pacing in patients with arrhythmias, such as bradycardia, to maintain a regular heart rhythm.
What specialties typically use this device?
Cardiologists and electrophysiologists typically use this device in hospital and specialized cardiac care settings.
What are the FDA-cleared indications?
The device is indicated for patients requiring cardiac pacing due to irregular heart rhythms, such as bradycardia or heart block.